| Human interleukin-1 alpha gene expression is regulated by Sp1 and a transcriptional repressor. McDowell T.L., Symons J.A., Duff G.W.
Cytokine 30:141-153(2005) · Mapped (7) |
| The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model. Symons J.A., Adams E., Tscharke D.C., Reading P.C., Waldmann H., Smith G.L.
J. Gen. Virol. 83:2833-2844(2002) · UniProtKB (1) |
| The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. Bartlett N., Symons J.A., Tscharke D.C., Smith G.L.
J. Gen. Virol. 83:1965-1976(2002) · UniProtKB (1) |
| A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence. Symons J.A., Tscharke D.C., Price N., Smith G.L.
J. Gen. Virol. 83:1953-1964(2002) · UniProtKB (1) |
| The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. Alcami A., Symons J.A., Smith G.L.
J. Virol. 74:11230-11239(2000) · UniProtKB (2) |
| Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. Alcami A., Symons J.A., Collins P.D., Williams T.J., Smith G.L.
J. Immunol. 160:624-633(1998) · UniProtKB (2) |
| Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. Symons J.A., Young P.R., Duff G.W.
Proc. Natl. Acad. Sci. U.S.A. 92:1714-1718(1995) · UniProtKB (1) |
| Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Symons J.A., Alcami A., Smith G.L.
Cell 81:551-560(1995) · UniProtKB (3) |
